Background: NETS NSW is called to 800 critically ill neonates per year. Many of these neonates require intensive care stabilisation prior to transport including central line access. Literature review of umbilical access in retrieval medicine and evaluation of the age up until UVC insertion is feasible reveals no current audits or case reports. In fact most studies on UVC use revolves around insertion technique, placement measurement tools, line associated infections and how to avoid them.
Background: Healthy term neonates have a drop in blood glucose at 1-2 h of life with a subsequent self-correcting nadir. The aim of this audit was to investigate the timing of first true blood glucose (TBG) and the incidence of neonatal hypoglycaemia in babies admitted to special care nursery.
Methods: Retrospective chart review of 393 neonates admitted to special care nursery at a tertiary hospital. Analyses were carried out and data entered included gestational age, reason for admission, time of first TBG and TBG result.
Results: Of 393 neonates admitted, 369 had a TBG during their admission. Almost 1 in 4 babies had a hypoglycaemic TBG on their first reading. 262 had a first TBG within 2 h of birth (120 min). The majority of babies (77%) had a first TBG within the first hour of birth. 21% of babies who had a first TBG from 0-60 min from birth were hypoglycaemic compared to 46% who had a first TBG between 61-120 min. 158 babies had a first normal TBG reading when taken from 0-60 min. 143 (91%) had a second TBG repeated. 12% of babies who had a second TBG within 60 min of birth were hypoglycaemic compared to 33% of babies who had a second TBG between 61-120 min.
Conclusions: More babies were hypoglycaemic when the first TBG was taken in the second hour of life than in the first hour of life. Delaying the time of the first TBG may capture more hypoglycaemic babies. Background: Nutritional supplementation of infants born small may improve development but increase risk of metabolic disease. We aimed to assess the effects of macronutrient supplements for infants born small on later development and metabolism.
Methods: Trials were included if the intention was to increase macronutrient intake to improve growth or development. Outcomes were evaluated in infancy (≤ 3 years) and childhood (3 to ≤8 years).
Results: In infancy, supplementation did not change the incidence of cognitive impairment (5 trials, 722 infants, relative risk (RR) = 0.99, 95%CI: 0.68, 1.46), or alter cognitive (13 trials, 1996 infants, mean difference (MD) = 0.36 95%CI: -0.97, 1.69) or motor scores (13 trials, 1996 infants, MD = 0.99, 95%CI: 0.56, 2.55). However, fewer supplemented infants had developmental impairment (5 trials, 515 infants, RR = 0.77, 95%CI: 0.63, 0.95). In subgroup analyses, supplementation improved cognitive scores in boys (2 trials, 201 infants, MD = 5.60, 95%CI: 1.07, 10.14), but not girls (2 trials, 212 infants, MD = −2.04, 95%CI: −7.04, 2.95). Supplemented and unsupplemented small-for-gestationalage infants had similar cognitive and motor scores (4 trials, 569 infants).
At 6 to 8 years, supplemented and unsupplemented groups had similar blood pressure (4 trials, 1115 infants). Supplemented children had lower fasting glucose (2 trials, 189 infants, MD = −0.20 mmol/L, 95%CI: −0.34, −0.06) and higher high-density lipoprotein concentrations (2 trials, 189 infants, MD = 0.11 mmol/L, 95% CI: 0.02, 0.19). Supplements did not alter triglyceride or low-density lipoprotein concentrations (2 trials, 189 infants).
Conclusions: Early macronutrient supplementation of preterm infants may decrease development impairment. Limited evidence suggests improved metabolic outcomes in childhood.
